サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1791631

DNAおよび遺伝子クローニング・サービスの世界市場

DNA and Gene Cloning Services

出版日
ページ情報
英文 178 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.90円
DNAおよび遺伝子クローニング・サービスの世界市場
出版日: 2025年08月15日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 178 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

DNAおよび遺伝子クローニング・サービスの世界市場は2030年までに78億米ドルに到達

2024年に31億米ドルと推定されるDNAおよび遺伝子クローニング・サービスの世界市場は、2024年から2030年にかけてCAGR 16.5%で成長し、2030年には78億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである遺伝子合成サービスは、CAGR18.0%を記録し、分析期間終了時には37億米ドルに達すると予想されます。カスタムクローニングサービス分野の成長率は、分析期間中CAGR13.5％と推定されます。

米国市場は8億2,220万米ドルと推定、中国はCAGR15.4％で成長予測

米国のDNAおよび遺伝子クローニング・サービス市場は、2024年には8億2,220万米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに12億米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは15.4%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ15.4％と14.1％と予測されています。欧州では、ドイツがCAGR 11.9%で成長すると予測されています。

世界のDNAおよび遺伝子クローニング・サービス市場- 主要動向と促進要因のまとめ

合成生物学の役割拡大がクローニングサービスの需要を高める？

合成生物学は、バイオテクノロジー、ヘルスケア、産業の各分野で前例のないイノベーションを推進し、変革をもたらす分野として急速に台頭しています。この動きの中心にあるのがDNAおよび遺伝子クローニング・サービスであり、遺伝物質を操作して新しい生物学的システムや製品を設計するための不可欠なツールとなっています。カスタム遺伝子合成、ベクター構築、プラスミドクローニングの需要の高まりは、次世代治療薬、ワクチン、診断薬、バイオベース材料の開発における合成生物学の応用の拡大と密接に結びついています。医薬品の研究開発では、治療用タンパク質の発現、遺伝子機能の研究、疾患モデルの構築に遺伝子クローニングが広く用いられています。さらに、COVID-19パンデミックを含む最近の世界の健康動向を受けて、ワクチン開発のための迅速な遺伝子工学の重要性がDNAおよび遺伝子クローニングを脚光を浴びています。クローニング・サービスは、研究者が特定のDNA配列を高い精度で複製することを可能にし、組み換えタンパク質やモノクローナル抗体を大規模に生産するのに不可欠です。学術機関、バイオテクノロジー企業、CRO（医薬品開発業務受託機関）の連携が進むにつれて、クローニング・サービスを高度な分子生物学的能力を持つ専門ベンダーが提供するアウトソーシングの動きが着実に広がっています。これらのベンダーは、遺伝子設計から発現検証までの統合ソリューションを提供し、研究スケジュールの合理化と技術的障壁の低減を実現しています。さらに、クローニングキット、自動化ツール、オンラインデザインプラットフォームが利用可能になったことで、専門家以外のラボへのアクセスが拡大し、遺伝子編集技術の利用が民主化されつつあります。CRISPR-Casシステムおよびゲノム工学の技術革新のペースが増しているため、遺伝子のノックイン、ノックアウト、突然変異誘発研究をサポートする高忠実度のクローニングサービスに対する需要がさらに加速しており、DNAおよび遺伝子のクローニングは生物工学の将来にとって中心的なものとなっています。

技術の進歩はクローニングプロセスの効率と精度を高めているか？

分子生物学とゲノミクスにおける技術の進歩は、DNAおよび遺伝子クローニング・サービスの効率性、正確性、拡張性を著しく向上させています。制限酵素やリガーゼを含む伝統的な方法は、ギブソンアセンブリー、ゴールデンゲートクローニング、部位特異的突然変異誘発といった、より洗練された技術へと進化し、より迅速でシームレスなDNAアセンブリーを可能にしています。これらの技術は、ベクターへの遺伝子配列の正確な挿入を可能にし、クローニングエラーを減らし、複雑な遺伝子回路の構築を可能にします。自動化はもう一つの大きな変革です。高スループットのロボット・システムは現在、反復的なクローニング作業を驚くべきスピードと再現性で実行し、サービス・プロバイダーが短納期で大量のカスタマイズされたDNA構築物を提供することを可能にしています。リアルタイムPCRや次世代シーケンシング（NGS）の検証と相まって、これらのシステムはクローニングのワークフロー全体にわたって高品質な管理を保証しています。人工知能もまた、特に大腸菌、酵母、哺乳類細胞などの様々な宿主生物における発現のための遺伝子配列最適化において、その役割を拡大しています。AIアルゴリズムは、コドンの使用法、mRNAの構造、GC含量を分析し、翻訳効率とタンパク質収量を向上させる。さらに、誘導性、マルチクローニング、組織特異的発現システムの開発など、ベクター設計の革新により、治療、農業、工業の各領域における遺伝子クローニングアプリケーションの汎用性が拡大した。クラウドベースのプロジェクト管理とLIMSプラットフォームにより、顧客とサービスプロバイダー間のシームレスなコミュニケーションが可能になり、透明性、トレーサビリティ、データ共有が改善されました。こうした技術的飛躍は、研究成果を向上させるだけでなく、特にクローン遺伝子の臨床および商業グレードの応用において、研究機関が厳格な規制および品質基準を満たすのに役立っています。精密なバイオテクノロジーへの需要が高まるにつれ、これらの最先端ツールの統合は、DNAおよび遺伝子クローニング・サービス.NETの新たなパフォーマンス・ベンチマークを設定し続けています。

アウトソーシングとカスタマイズへのシフトはサービス提供モデルを再定義するか？

バイオテクノロジーや製薬研究がますます複雑化し、データ駆動型になるにつれ、組織は開発期間を短縮し、専門的な専門知識を利用するための戦略的な動きとしてアウトソーシングに目を向けています。DNAおよび遺伝子クローニング・サービスはこのアウトソーシング動向の最前線にあり、遺伝子合成、ベクター・エンジニアリング、発現検証、ライブラリー構築などの作業において、企業は外部パートナーを選好しています。アウトソーシング・モデルには、プロジェクトの迅速なターンアラウンド、専門的なインフラへのアクセス、コスト効率といった明確な利点があります。大手サービスプロバイダーは現在、高度にカスタマイズ可能なソリューションを提供しており、顧客は長さ、配列、タグ、発現システム、さらにはコドン最適化の好みに基づいて遺伝子コンストラクトを指定することができます。このレベルのカスタマイズは、合成開始前に遺伝子設計、エラーチェック、最適化を支援する高度なバイオインフォマティクス・プラットフォームによってサポートされています。さらに、タンパク質発現、精製、機能アッセイなどの下流のアプリケーションとサービスがバンドルされることも多く、エンドツーエンドの分子生物学的ソリューションを一元的に提供しています。クローン化された遺伝子配列は技術革新のパイプラインにとって重要な専有情報であることが多いため、知的財産権の保護と機密性も重視されるようになっています。各社は、ブロックチェーンを利用したサンプル追跡や配列の暗号化配信など、厳格なデータ・セキュリティ・プロトコルを導入することで対応しています。特に中国やインドなどのアジア太平洋地域では、サービスプロバイダーの世界の拡大が進んでおり、品質に妥協することなく費用対効果の高い選択肢を提供し、競争とイノベーションをさらに激化させています。学術機関もまた、大規模な共同プロジェクトのために、クローニング・サービスを大規模に利用するために、商業プロバイダーと提携することが増えています。サービス提供におけるこのシフトは、研究の生産性を最適化するだけでなく、DNAおよび遺伝子クローニングを、より広範なライフサイエンス・エコシステムにおける重要なアウトソーシング・ユーティリティとして確立しつつあります。

DNAおよび遺伝子クローニング・サービス市場を加速する主な成長要因は何か？

DNAおよび遺伝子クローニング・サービス市場の成長は、バイオテクノロジーやライフサイエンスにおける技術の進歩、調査の多様化、消費者行動の変化に直接関連するいくつかの要因によって牽引されています。主な促進要因の1つは、合成生物学、免疫療法、ワクチン開発、農業バイオテクノロジーなどの分野で遺伝子調査範囲が拡大していることであり、これらはすべて、実験的および治療的使用のための機能的構築物を作成するために遺伝子クローニングに大きく依存しています。CRISPR-Cas9やTALENのような遺伝子編集技術の広範な採用は、疾患モデリングや機能的遺伝子スクリーニングのためであれ、遺伝子改変をサポートする精密なクローニングサービスの必要性をさらに高めています。これと並行して、バイオ医薬品パイプラインにおけるモノクローナル抗体、細胞ベース療法、組換えタンパク質の台頭は、クローニングによって構築された信頼性の高い発現系に対する持続的な需要を生み出しています。もう一つの重要な要因は、ライフサイエンスにおける分散化の動向です。中小企業（SME）、学術スピンオフ企業、独立研究所は、より野心的なプロジェクトに挑んでいるが、複雑なクローニング作業のための社内能力が不足していることが多く、そのため専門のサービスプロバイダーに頼っています。個別化医療や標的療法に向けた世界の動きも、個々の患者プロファイルやニッチな適応症に合わせたカスタム遺伝子コンストラクトの需要に拍車をかけています。さらに、創薬標的、酵素、結合ドメインのスクリーニングのための合成遺伝子ライブラリーの開発は、従来の研究用途を超えてクローニングサービスの有用性を拡大しています。自動化されたハイスループット・システム、AI主導の配列設計、高度なベクター・システムなどの技術的イネーブラーは、拡張性と信頼性を向上させており、プロバイダーは複雑な要件を持つより多様な顧客にサービスを提供できるようになっています。最後に、国際的な共同研究、研究助成金、政府が支援するゲノム・イニシアティブは、分子生物学インフラに多額の資金を投入し、持続的な市場拡大のための肥沃な土壌を作り出しています。このような総合的な力によって、市場の裾野が広がっているだけでなく、DNAおよび遺伝子クローニング・サービスが現代のバイオサイエンス革新の基本的な要素として確固たる地位を築きつつあります。

セグメント

サービス（遺伝子合成サービス、カスタムクローニングサービス、サブクローニングサービス、その他サービス）、用途（DNAシーケンス用途、突然変異誘発用途、遺伝子型判定用途、その他用途）、最終用途（学術・研究機関最終用途、製薬・バイオ企業最終用途、CMO・CRO最終用途）

調査対象企業の例

  • abm Inc.（Applied Biological Materials）
  • ATUM
  • Bio Basic Inc.
  • BioCat GmbH
  • Biolegio B.V.
  • BioS&T
  • Blue Heron Biotech
  • Creative Biogene
  • Dundee Cell Products
  • Eurofins Genomics
  • Eurogentec
  • GenScript
  • GENEWIZ from Azenta Life Sciences
  • Genovac
  • GenScript Biotech Corporation
  • Integrated DNA Technologies（IDT）
  • Invitrogen（Thermo Fisher Scientific）
  • Macrogen
  • OriGene Technologies
  • ProteoGenix

AIインテグレーション

Global Industry Analystsは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、一般的なLLMや業界別SLMのクエリに従う代わりに、ビデオ記録、ブログ、検索エンジン調査、大量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • その他の地域

第4章 競合

目次
Product Code: MCP30555

Global DNA and Gene Cloning Services Market to Reach US$7.8 Billion by 2030

The global market for DNA and Gene Cloning Services estimated at US$3.1 Billion in the year 2024, is expected to reach US$7.8 Billion by 2030, growing at a CAGR of 16.5% over the analysis period 2024-2030. Gene Synthesis Service, one of the segments analyzed in the report, is expected to record a 18.0% CAGR and reach US$3.7 Billion by the end of the analysis period. Growth in the Custom Cloning Service segment is estimated at 13.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$822.2 Million While China is Forecast to Grow at 15.4% CAGR

The DNA and Gene Cloning Services market in the U.S. is estimated at US$822.2 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.2 Billion by the year 2030 trailing a CAGR of 15.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 15.4% and 14.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 11.9% CAGR.

Global DNA and Gene Cloning Services Market - Key Trends & Drivers Summarized

Is the Expanding Role of Synthetic Biology Elevating the Demand for Cloning Services?

Synthetic biology has rapidly emerged as a transformative field, driving unprecedented innovation across biotechnology, healthcare, and industrial sectors. At the heart of this movement lies DNA and gene cloning services, which have become essential tools for manipulating genetic material to design novel biological systems and products. The rising demand for custom gene synthesis, vector construction, and plasmid cloning is closely tied to the growing applications of synthetic biology in developing next-generation therapeutics, vaccines, diagnostics, and bio-based materials. In pharmaceutical R&D, gene cloning is used extensively to express therapeutic proteins, study gene function, and engineer disease models. Moreover, in the wake of recent global health challenges, including the COVID-19 pandemic, the importance of rapid genetic engineering for vaccine development has pushed DNA and gene cloning into the spotlight. Cloning services enable researchers to replicate specific DNA sequences with high precision, which is vital for producing recombinant proteins and monoclonal antibodies at scale. The growing collaboration between academic institutions, biotech firms, and contract research organizations (CROs) has led to a steady outsourcing trend, where cloning services are provided by specialized vendors with advanced molecular biology capabilities. These vendors offer integrated solutions-from gene design to expression validation-streamlining research timelines and reducing technical barriers. Additionally, the availability of cloning kits, automation tools, and online design platforms is expanding access to non-specialist labs, democratizing the use of gene editing technologies. The increasing pace of innovation in CRISPR-Cas systems and genome engineering is further accelerating demand for high-fidelity cloning services that support gene knock-ins, knockouts, and mutagenesis studies, making DNA and gene cloning central to the future of bioengineering.

Are Technological Advancements Enhancing the Efficiency and Precision of Cloning Processes?

Technological advancements in molecular biology and genomics are significantly enhancing the efficiency, accuracy, and scalability of DNA and gene cloning services. Traditional methods involving restriction enzymes and ligases have evolved into more sophisticated techniques such as Gibson Assembly, Golden Gate cloning, and site-directed mutagenesis, enabling faster and more seamless DNA assembly. These techniques allow for the precise insertion of genetic sequences into vectors, reducing cloning errors and enabling the construction of complex genetic circuits. Automation is another major game-changer-high-throughput robotic systems now perform repetitive cloning tasks with remarkable speed and reproducibility, allowing service providers to deliver large volumes of customized DNA constructs within short turnaround times. Coupled with real-time PCR and next-generation sequencing (NGS) validation, these systems ensure high-quality control across the cloning workflow. Artificial intelligence is also playing a growing role, particularly in gene sequence optimization for expression in various host organisms, such as E. coli, yeast, or mammalian cells. AI algorithms analyze codon usage, mRNA structure, and GC content to improve translation efficiency and protein yield. Furthermore, innovations in vector design-such as the development of inducible, multi-cloning, and tissue-specific expression systems-have expanded the versatility of gene cloning applications across therapeutic, agricultural, and industrial domains. Cloud-based project management and LIMS platforms now allow seamless communication between clients and service providers, improving transparency, traceability, and data sharing. These technological leaps are not only improving research output but also helping institutions meet rigorous regulatory and quality standards, particularly in clinical and commercial-grade applications of cloned genes. As the demand for precision biotechnology rises, the integration of these cutting-edge tools continues to set new performance benchmarks for DNA and gene cloning services.

Is the Shift Toward Outsourcing and Customization Redefining Service Delivery Models?

As biotechnology and pharmaceutical research becomes increasingly complex and data-driven, organizations are turning to outsourcing as a strategic move to accelerate development timelines and access specialized expertise. DNA and gene cloning services are at the forefront of this outsourcing trend, with companies preferring external partners for tasks such as gene synthesis, vector engineering, expression validation, and library construction. The outsourcing model offers clear advantages: faster project turnaround, access to specialized infrastructure, and cost efficiency-especially for smaller labs and startups with limited in-house capabilities. Leading service providers now offer highly customizable solutions, where clients can specify gene constructs based on length, sequence, tags, expression systems, and even codon optimization preferences. This level of customization is supported by advanced bioinformatics platforms that assist in gene design, error checking, and optimization before synthesis begins. Additionally, services are often bundled with downstream applications such as protein expression, purification, and functional assays, providing end-to-end molecular biology solutions under one roof. There is also a growing emphasis on IP protection and confidentiality, as cloned genetic sequences often represent proprietary information critical to innovation pipelines. Companies are responding by implementing stringent data security protocols, including blockchain-based sample tracking and encrypted sequence delivery. Global expansion of service providers, particularly in Asia-Pacific regions like China and India, is driving cost-effective options without compromising quality, further intensifying competition and innovation. Academic institutions, too, are increasingly partnering with commercial providers to access cloning services at scale for large collaborative projects. This shift in service delivery is not only optimizing research productivity but is also establishing DNA and gene cloning as a critical outsourced utility in the broader life sciences ecosystem.

What Are the Main Growth Accelerators Fueling the DNA and Gene Cloning Services Market?

The growth in the DNA and gene cloning services market is driven by several factors directly linked to technological progression, research diversification, and shifting consumer behavior in biotech and life sciences. One of the primary accelerators is the expanding scope of genetic research in fields such as synthetic biology, immunotherapy, vaccine development, and agricultural biotech, all of which rely heavily on gene cloning to create functional constructs for experimental and therapeutic use. The widespread adoption of gene editing technologies like CRISPR-Cas9 and TALEN has further increased the need for precise cloning services to support genetic modifications, whether for disease modeling or functional gene screening. In parallel, the rise of monoclonal antibodies, cell-based therapies, and recombinant proteins in biopharmaceutical pipelines is generating sustained demand for reliable expression systems constructed through cloning. Another significant factor is the trend toward decentralization in life sciences, where small and mid-sized enterprises (SMEs), academic spin-offs, and independent research labs are taking on more ambitious projects, yet often lack the in-house capabilities for complex cloning tasks-thus turning to specialized service providers. The global movement toward personalized medicine and targeted therapies is also fueling demand for custom gene constructs tailored to individual patient profiles or niche indications. Moreover, the development of synthetic gene libraries for screening drug targets, enzymes, or binding domains is expanding the utility of cloning services beyond traditional research applications. Technological enablers such as automated high-throughput systems, AI-driven sequence design, and advanced vector systems are improving scalability and reliability, allowing providers to serve a more diverse clientele with complex requirements. Finally, international collaborations, research grants, and government-backed genomic initiatives are injecting substantial funding into molecular biology infrastructure, creating fertile ground for sustained market expansion. These collective forces are not only broadening the market base but are solidifying DNA and gene cloning services as a fundamental component of modern bioscience innovation.

SCOPE OF STUDY:

The report analyzes the DNA and Gene Cloning Services market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Service (Gene Synthesis Service, Custom Cloning Service, Sub-cloning Service, Other Services); Application (DNA Sequencing Application, Mutagenesis Application, Genotyping Application, Other Applications); End-Use (Academic & Research Institutes End-Use, Pharma & Biotech Companies End-Use, CMOs & CROs End-Use)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 42 Featured) -

  • abm Inc. (Applied Biological Materials)
  • ATUM
  • Bio Basic Inc.
  • BioCat GmbH
  • Biolegio B.V.
  • BioS&T
  • Blue Heron Biotech
  • Creative Biogene
  • Dundee Cell Products
  • Eurofins Genomics
  • Eurogentec
  • GenScript
  • GENEWIZ from Azenta Life Sciences
  • Genovac
  • GenScript Biotech Corporation
  • Integrated DNA Technologies (IDT)
  • Invitrogen (Thermo Fisher Scientific)
  • Macrogen
  • OriGene Technologies
  • ProteoGenix

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • DNA and Gene Cloning Services - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Boom in Synthetic Biology Research Throws the Spotlight on Scalable DNA and Gene Cloning Solutions
    • Expanding Use of Gene Cloning in Drug Discovery and Development Propels Growth in Service Demand
    • Rise of Personalized and Targeted Therapies Strengthens Business Case for Customized Gene Constructs
    • Proliferation of CRISPR and Genome Editing Applications Drives Adoption of High-Precision Cloning Services
    • Increasing Outsourcing by Biopharma and Academic Institutions Expands Addressable Market for Specialized Providers
    • Integration of AI and Bioinformatics in Gene Design Accelerates Demand for Intelligent Cloning Platforms
    • Growth of Monoclonal Antibody and Recombinant Protein Production Spurs Demand for Expression-Ready Clones
    • Emergence of High-Throughput and Automated Cloning Workflows Enhances Operational Efficiency and Scalability
    • Adoption of Cloud-Based Platforms for Sequence Management Drives Digital Transformation in Cloning Services
    • Surge in Synthetic Gene Library Construction Generates Opportunities in Functional Genomics and Screening
    • Rising Interest in Rare Disease Research and Orphan Drug Development Spurs Need for Specialized Cloning Capabilities
    • Expansion of Agri-Biotech and Industrial Biotech Pipelines Propels Demand Beyond Traditional Life Sciences Sectors
    • Emphasis on Data Security, IP Protection, and Confidentiality Enhances Trust in Third-Party Gene Cloning Services
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World DNA and Gene Cloning Services Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for DNA and Gene Cloning Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World 6-Year Perspective for DNA and Gene Cloning Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Gene Synthesis Service by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 5: World 6-Year Perspective for Gene Synthesis Service by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Custom Cloning Service by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 7: World 6-Year Perspective for Custom Cloning Service by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Sub-cloning Service by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World 6-Year Perspective for Sub-cloning Service by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Other Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 11: World 6-Year Perspective for Other Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 13: World 6-Year Perspective for Pharma & Biotech Companies End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for CMOs & CROs End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World 6-Year Perspective for CMOs & CROs End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Academic & Research Institutes End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 17: World 6-Year Perspective for Academic & Research Institutes End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 18: World Recent Past, Current & Future Analysis for DNA Sequencing Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 19: World 6-Year Perspective for DNA Sequencing Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Mutagenesis Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World 6-Year Perspective for Mutagenesis Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Genotyping Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 23: World 6-Year Perspective for Genotyping Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 24: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 25: World 6-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • DNA and Gene Cloning Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 26: USA Recent Past, Current & Future Analysis for DNA and Gene Cloning Services by Service - Gene Synthesis Service, Custom Cloning Service, Sub-cloning Service and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA 6-Year Perspective for DNA and Gene Cloning Services by Service - Percentage Breakdown of Value Sales for Gene Synthesis Service, Custom Cloning Service, Sub-cloning Service and Other Services for the Years 2025 & 2030
    • TABLE 28: USA Recent Past, Current & Future Analysis for DNA and Gene Cloning Services by End-Use - Pharma & Biotech Companies End-Use, CMOs & CROs End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 29: USA 6-Year Perspective for DNA and Gene Cloning Services by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, CMOs & CROs End-Use and Academic & Research Institutes End-Use for the Years 2025 & 2030
    • TABLE 30: USA Recent Past, Current & Future Analysis for DNA and Gene Cloning Services by Application - DNA Sequencing Application, Mutagenesis Application, Genotyping Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 31: USA 6-Year Perspective for DNA and Gene Cloning Services by Application - Percentage Breakdown of Value Sales for DNA Sequencing Application, Mutagenesis Application, Genotyping Application and Other Applications for the Years 2025 & 2030
  • CANADA
    • TABLE 32: Canada Recent Past, Current & Future Analysis for DNA and Gene Cloning Services by Service - Gene Synthesis Service, Custom Cloning Service, Sub-cloning Service and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada 6-Year Perspective for DNA and Gene Cloning Services by Service - Percentage Breakdown of Value Sales for Gene Synthesis Service, Custom Cloning Service, Sub-cloning Service and Other Services for the Years 2025 & 2030
    • TABLE 34: Canada Recent Past, Current & Future Analysis for DNA and Gene Cloning Services by End-Use - Pharma & Biotech Companies End-Use, CMOs & CROs End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 35: Canada 6-Year Perspective for DNA and Gene Cloning Services by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, CMOs & CROs End-Use and Academic & Research Institutes End-Use for the Years 2025 & 2030
    • TABLE 36: Canada Recent Past, Current & Future Analysis for DNA and Gene Cloning Services by Application - DNA Sequencing Application, Mutagenesis Application, Genotyping Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 37: Canada 6-Year Perspective for DNA and Gene Cloning Services by Application - Percentage Breakdown of Value Sales for DNA Sequencing Application, Mutagenesis Application, Genotyping Application and Other Applications for the Years 2025 & 2030
  • JAPAN
    • DNA and Gene Cloning Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 38: Japan Recent Past, Current & Future Analysis for DNA and Gene Cloning Services by Service - Gene Synthesis Service, Custom Cloning Service, Sub-cloning Service and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan 6-Year Perspective for DNA and Gene Cloning Services by Service - Percentage Breakdown of Value Sales for Gene Synthesis Service, Custom Cloning Service, Sub-cloning Service and Other Services for the Years 2025 & 2030
    • TABLE 40: Japan Recent Past, Current & Future Analysis for DNA and Gene Cloning Services by End-Use - Pharma & Biotech Companies End-Use, CMOs & CROs End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 41: Japan 6-Year Perspective for DNA and Gene Cloning Services by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, CMOs & CROs End-Use and Academic & Research Institutes End-Use for the Years 2025 & 2030
    • TABLE 42: Japan Recent Past, Current & Future Analysis for DNA and Gene Cloning Services by Application - DNA Sequencing Application, Mutagenesis Application, Genotyping Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 43: Japan 6-Year Perspective for DNA and Gene Cloning Services by Application - Percentage Breakdown of Value Sales for DNA Sequencing Application, Mutagenesis Application, Genotyping Application and Other Applications for the Years 2025 & 2030
  • CHINA
    • DNA and Gene Cloning Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 44: China Recent Past, Current & Future Analysis for DNA and Gene Cloning Services by Service - Gene Synthesis Service, Custom Cloning Service, Sub-cloning Service and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China 6-Year Perspective for DNA and Gene Cloning Services by Service - Percentage Breakdown of Value Sales for Gene Synthesis Service, Custom Cloning Service, Sub-cloning Service and Other Services for the Years 2025 & 2030
    • TABLE 46: China Recent Past, Current & Future Analysis for DNA and Gene Cloning Services by End-Use - Pharma & Biotech Companies End-Use, CMOs & CROs End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 47: China 6-Year Perspective for DNA and Gene Cloning Services by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, CMOs & CROs End-Use and Academic & Research Institutes End-Use for the Years 2025 & 2030
    • TABLE 48: China Recent Past, Current & Future Analysis for DNA and Gene Cloning Services by Application - DNA Sequencing Application, Mutagenesis Application, Genotyping Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 49: China 6-Year Perspective for DNA and Gene Cloning Services by Application - Percentage Breakdown of Value Sales for DNA Sequencing Application, Mutagenesis Application, Genotyping Application and Other Applications for the Years 2025 & 2030
  • EUROPE
    • DNA and Gene Cloning Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 50: Europe Recent Past, Current & Future Analysis for DNA and Gene Cloning Services by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe 6-Year Perspective for DNA and Gene Cloning Services by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 52: Europe Recent Past, Current & Future Analysis for DNA and Gene Cloning Services by Service - Gene Synthesis Service, Custom Cloning Service, Sub-cloning Service and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 53: Europe 6-Year Perspective for DNA and Gene Cloning Services by Service - Percentage Breakdown of Value Sales for Gene Synthesis Service, Custom Cloning Service, Sub-cloning Service and Other Services for the Years 2025 & 2030
    • TABLE 54: Europe Recent Past, Current & Future Analysis for DNA and Gene Cloning Services by End-Use - Pharma & Biotech Companies End-Use, CMOs & CROs End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 55: Europe 6-Year Perspective for DNA and Gene Cloning Services by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, CMOs & CROs End-Use and Academic & Research Institutes End-Use for the Years 2025 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for DNA and Gene Cloning Services by Application - DNA Sequencing Application, Mutagenesis Application, Genotyping Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe 6-Year Perspective for DNA and Gene Cloning Services by Application - Percentage Breakdown of Value Sales for DNA Sequencing Application, Mutagenesis Application, Genotyping Application and Other Applications for the Years 2025 & 2030
  • FRANCE
    • DNA and Gene Cloning Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 58: France Recent Past, Current & Future Analysis for DNA and Gene Cloning Services by Service - Gene Synthesis Service, Custom Cloning Service, Sub-cloning Service and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 59: France 6-Year Perspective for DNA and Gene Cloning Services by Service - Percentage Breakdown of Value Sales for Gene Synthesis Service, Custom Cloning Service, Sub-cloning Service and Other Services for the Years 2025 & 2030
    • TABLE 60: France Recent Past, Current & Future Analysis for DNA and Gene Cloning Services by End-Use - Pharma & Biotech Companies End-Use, CMOs & CROs End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 61: France 6-Year Perspective for DNA and Gene Cloning Services by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, CMOs & CROs End-Use and Academic & Research Institutes End-Use for the Years 2025 & 2030
    • TABLE 62: France Recent Past, Current & Future Analysis for DNA and Gene Cloning Services by Application - DNA Sequencing Application, Mutagenesis Application, Genotyping Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: France 6-Year Perspective for DNA and Gene Cloning Services by Application - Percentage Breakdown of Value Sales for DNA Sequencing Application, Mutagenesis Application, Genotyping Application and Other Applications for the Years 2025 & 2030
  • GERMANY
    • DNA and Gene Cloning Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 64: Germany Recent Past, Current & Future Analysis for DNA and Gene Cloning Services by Service - Gene Synthesis Service, Custom Cloning Service, Sub-cloning Service and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 65: Germany 6-Year Perspective for DNA and Gene Cloning Services by Service - Percentage Breakdown of Value Sales for Gene Synthesis Service, Custom Cloning Service, Sub-cloning Service and Other Services for the Years 2025 & 2030
    • TABLE 66: Germany Recent Past, Current & Future Analysis for DNA and Gene Cloning Services by End-Use - Pharma & Biotech Companies End-Use, CMOs & CROs End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 67: Germany 6-Year Perspective for DNA and Gene Cloning Services by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, CMOs & CROs End-Use and Academic & Research Institutes End-Use for the Years 2025 & 2030
    • TABLE 68: Germany Recent Past, Current & Future Analysis for DNA and Gene Cloning Services by Application - DNA Sequencing Application, Mutagenesis Application, Genotyping Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Germany 6-Year Perspective for DNA and Gene Cloning Services by Application - Percentage Breakdown of Value Sales for DNA Sequencing Application, Mutagenesis Application, Genotyping Application and Other Applications for the Years 2025 & 2030
  • ITALY
    • TABLE 70: Italy Recent Past, Current & Future Analysis for DNA and Gene Cloning Services by Service - Gene Synthesis Service, Custom Cloning Service, Sub-cloning Service and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 71: Italy 6-Year Perspective for DNA and Gene Cloning Services by Service - Percentage Breakdown of Value Sales for Gene Synthesis Service, Custom Cloning Service, Sub-cloning Service and Other Services for the Years 2025 & 2030
    • TABLE 72: Italy Recent Past, Current & Future Analysis for DNA and Gene Cloning Services by End-Use - Pharma & Biotech Companies End-Use, CMOs & CROs End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 73: Italy 6-Year Perspective for DNA and Gene Cloning Services by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, CMOs & CROs End-Use and Academic & Research Institutes End-Use for the Years 2025 & 2030
    • TABLE 74: Italy Recent Past, Current & Future Analysis for DNA and Gene Cloning Services by Application - DNA Sequencing Application, Mutagenesis Application, Genotyping Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Italy 6-Year Perspective for DNA and Gene Cloning Services by Application - Percentage Breakdown of Value Sales for DNA Sequencing Application, Mutagenesis Application, Genotyping Application and Other Applications for the Years 2025 & 2030
  • UNITED KINGDOM
    • DNA and Gene Cloning Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 76: UK Recent Past, Current & Future Analysis for DNA and Gene Cloning Services by Service - Gene Synthesis Service, Custom Cloning Service, Sub-cloning Service and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 77: UK 6-Year Perspective for DNA and Gene Cloning Services by Service - Percentage Breakdown of Value Sales for Gene Synthesis Service, Custom Cloning Service, Sub-cloning Service and Other Services for the Years 2025 & 2030
    • TABLE 78: UK Recent Past, Current & Future Analysis for DNA and Gene Cloning Services by End-Use - Pharma & Biotech Companies End-Use, CMOs & CROs End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 79: UK 6-Year Perspective for DNA and Gene Cloning Services by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, CMOs & CROs End-Use and Academic & Research Institutes End-Use for the Years 2025 & 2030
    • TABLE 80: UK Recent Past, Current & Future Analysis for DNA and Gene Cloning Services by Application - DNA Sequencing Application, Mutagenesis Application, Genotyping Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: UK 6-Year Perspective for DNA and Gene Cloning Services by Application - Percentage Breakdown of Value Sales for DNA Sequencing Application, Mutagenesis Application, Genotyping Application and Other Applications for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 82: Rest of Europe Recent Past, Current & Future Analysis for DNA and Gene Cloning Services by Service - Gene Synthesis Service, Custom Cloning Service, Sub-cloning Service and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 83: Rest of Europe 6-Year Perspective for DNA and Gene Cloning Services by Service - Percentage Breakdown of Value Sales for Gene Synthesis Service, Custom Cloning Service, Sub-cloning Service and Other Services for the Years 2025 & 2030
    • TABLE 84: Rest of Europe Recent Past, Current & Future Analysis for DNA and Gene Cloning Services by End-Use - Pharma & Biotech Companies End-Use, CMOs & CROs End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 85: Rest of Europe 6-Year Perspective for DNA and Gene Cloning Services by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, CMOs & CROs End-Use and Academic & Research Institutes End-Use for the Years 2025 & 2030
    • TABLE 86: Rest of Europe Recent Past, Current & Future Analysis for DNA and Gene Cloning Services by Application - DNA Sequencing Application, Mutagenesis Application, Genotyping Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Rest of Europe 6-Year Perspective for DNA and Gene Cloning Services by Application - Percentage Breakdown of Value Sales for DNA Sequencing Application, Mutagenesis Application, Genotyping Application and Other Applications for the Years 2025 & 2030
  • ASIA-PACIFIC
    • DNA and Gene Cloning Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 88: Asia-Pacific Recent Past, Current & Future Analysis for DNA and Gene Cloning Services by Service - Gene Synthesis Service, Custom Cloning Service, Sub-cloning Service and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 89: Asia-Pacific 6-Year Perspective for DNA and Gene Cloning Services by Service - Percentage Breakdown of Value Sales for Gene Synthesis Service, Custom Cloning Service, Sub-cloning Service and Other Services for the Years 2025 & 2030
    • TABLE 90: Asia-Pacific Recent Past, Current & Future Analysis for DNA and Gene Cloning Services by End-Use - Pharma & Biotech Companies End-Use, CMOs & CROs End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 91: Asia-Pacific 6-Year Perspective for DNA and Gene Cloning Services by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, CMOs & CROs End-Use and Academic & Research Institutes End-Use for the Years 2025 & 2030
    • TABLE 92: Asia-Pacific Recent Past, Current & Future Analysis for DNA and Gene Cloning Services by Application - DNA Sequencing Application, Mutagenesis Application, Genotyping Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Asia-Pacific 6-Year Perspective for DNA and Gene Cloning Services by Application - Percentage Breakdown of Value Sales for DNA Sequencing Application, Mutagenesis Application, Genotyping Application and Other Applications for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 94: Rest of World Recent Past, Current & Future Analysis for DNA and Gene Cloning Services by Service - Gene Synthesis Service, Custom Cloning Service, Sub-cloning Service and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 95: Rest of World 6-Year Perspective for DNA and Gene Cloning Services by Service - Percentage Breakdown of Value Sales for Gene Synthesis Service, Custom Cloning Service, Sub-cloning Service and Other Services for the Years 2025 & 2030
    • TABLE 96: Rest of World Recent Past, Current & Future Analysis for DNA and Gene Cloning Services by End-Use - Pharma & Biotech Companies End-Use, CMOs & CROs End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 97: Rest of World 6-Year Perspective for DNA and Gene Cloning Services by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, CMOs & CROs End-Use and Academic & Research Institutes End-Use for the Years 2025 & 2030
    • TABLE 98: Rest of World Recent Past, Current & Future Analysis for DNA and Gene Cloning Services by Application - DNA Sequencing Application, Mutagenesis Application, Genotyping Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Rest of World 6-Year Perspective for DNA and Gene Cloning Services by Application - Percentage Breakdown of Value Sales for DNA Sequencing Application, Mutagenesis Application, Genotyping Application and Other Applications for the Years 2025 & 2030

IV. COMPETITION